Listing single

How Chinese precision medicine play 3DMed is charting course to public markets

Chinese cancer company 3D Medicines Corp. is vying for a Hong Kong or NASDAQ listing this year and is restructuring as a Cayman Islands-based entity in order to tap public funds while keeping its diagnostics and therapeutics businesses under one roof.

3DMed markets next-generation sequencing-based cancer diagnostics in China and

Read the full 501 word article

User Sign In